The long term objective of our research is to understand the biology of the terminal complement complex (TCC) which includes C5b-7, C5b-8, and C5b-9. C5b-9 mediated nucleated cell killing is governed by a multi-step process: sequential assembly of TCC in the membrane, elimination of potentially lytic C5b-9 from the cell surface, and the process of cell death elicited by C5b-9. Once TCC is assembled, it is subjected to rapid elimination from the cell surface. TCC elimination, vital for cell survival, is enhanced by increased cytosolic Ca2+, [Ca2+] i, in a protein kinase C (PKC) -dependent manner when the number of TCC is limiting. Since elimination of complement channels depends on signals generated by TCC and TCC is known to be a potent inducer of cell activation, the effect of C5b-7, C5b-8, and sublytic C5b-9 channels may be of major biological importance in cells surviving from limited complement attack in vivo. Other than Ca2+ influx and increase in [Ca 2+ ]i, little is known about whether and how TCC generates other signal messengers. Interestingly, some of the biological activities of C5b-9 can be achieved by C5b-7 and/or C5b-8 with little or no Ca2+ influx, which suggests that mediators other than Ca2+ may be involved. We have been able to demonstrate that TCC, especially C5b-7, increased the mass levels of diacylglycerol (DAG) and ceramide, potent second messengers, in a human JY B cell line and in a murine C2 muscle cell line. These findings are potentially significant to understand the pathobiology of affected cells in autoimmune diseases in which functionally important cells such as B-cells and muscle cells are targeted by auto-antibodies. In this proposal, we will examine (1) TCC-induced signal messengers, specifically DAG and ceramide, and the mechanisms of their generation by analyzing G protein activation, (2) the regulatory effect of TCC on the expression of muscle-specific proteins in C2 mytotubes by examining post-transcriptional stability of mRNAs encoding these proteins, and (3) the mechanisms of nucleated cell killing mediated by C5b-9 by exploring the effect of uncontrolled calcium influx on the functional status of mitochondria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019622-13
Application #
2060967
Study Section
Experimental Immunology Study Section (EI)
Project Start
1983-01-01
Project End
1997-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
13
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Pathology
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Niculescu, F; Soane, L; Badea, T et al. (1999) Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells. Immunopharmacology 42:187-93
Lokuta, M A; Maher, J; Noe, K H et al. (1996) Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus. J Biol Chem 271:13731-8
Papadimitriou, J C; Phelps, P C; Shin, M L et al. (1994) Effects of Ca2+ deregulation on mitochondrial membrane potential and cell viability in nucleated cells following lytic complement attack. Cell Calcium 15:217-27
Papadimitriou, J C; Drachenberg, C B; Shin, M L et al. (1994) Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Arch 424:677-85
Niculescu, F; Rus, H; Shin, M L (1994) Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J Biol Chem 269:4417-23
Niculescu, F; Rus, H; Shin, S et al. (1993) Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol 150:214-24
Shirazi, Y; Rus, H G; Macklin, W B et al. (1993) Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol 150:4581-90
Rus, H G; Kim, L M; Niculescu, F I et al. (1992) Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J Immunol 148:928-33
Lee, S C; Collins, M; Vanguri, P et al. (1992) Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol 148:3391-7
Papadimitriou, J C; Carney, D F; Shin, M L (1991) Inhibitors of membrane lipid metabolism enhance complement-mediated nucleated cell killing through distinct mechanisms. Mol Immunol 28:803-9

Showing the most recent 10 out of 26 publications